A novel mouse model of a patient mucolipidosis II mutation recapitulates disease pathology.
Mucolipidosis II (MLII) is a lysosomal storage disorder caused by loss of N-acetylglucosamine-1-phosphotransferase, which tags lysosomal enzymes with a mannose 6-phosphate marker for transport to the lysosome. In MLII, the loss of this marker leads to deficiency of multiple enzymes and non-enzymatic...
Main Authors: | Paton, L, Bitoun, E, Kenyon, J, Priestman, D, Oliver, P, Edwards, B, Platt, F, Davies, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Society for Biochemistry and Molecular Biology Inc.
2014
|
Similar Items
-
Neurologic abnormalities in mouse models of the lysosomal storage disorders mucolipidosis II and mucolipidosis III γ.
by: Rachel A Idol, et al.
Published: (2014-01-01) -
Correction: Neurologic Abnormalities in Mouse Models of the Lysosomal Storage Disorders Mucolipidosis II and Mucolipidosis III γ
Published: (2014-01-01) -
Quaternary diagnostics scheme for mucolipidosis II and detection of novel mutation in GNPTAB gene
by: Mona L. Essawi, et al.
Published: (2021-08-01) -
Outcomes after HSCT for mucolipidosis II (I-cell disease) caused by novel compound heterozygous GNPTAB mutations
by: Si-jia He, et al.
Published: (2023-07-01) -
Comorbid Cardiovascular Malformation and Type II Mucolipidosis: Clinical Case
by: Nina V. Fedorova, et al.
Published: (2020-11-01)